Menghini, M <br/><br/>
Response to ranibizumab therapy in neovascular AMD - an evaluation of good and bad responders.  [electronic resource] 

 -  Klinische Monatsblatter fur Augenheilkunde  Apr 2010 
 - 244-8 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1439-3999 
<br/><br/><label>Standard No.: </label>10.1055/s-0029-1245203  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antibodies, Monoclonal--administration & dosage<br/>Antibodies, Monoclonal, Humanized<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Male<br/>Prevalence<br/>Prognosis<br/>Ranibizumab<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Sex Distribution<br/>Switzerland--epidemiology<br/>Treatment Outcome